SCHEMBL24656575

SCHEMBL24656575

Cc1nc(C2CC2)n2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 3/20 0.50
▸ CNR2 P34972 2/20 0.50
▸ PTPN2 P17706 1/20 0.50
▸ SSTR4 P31391 2/20 0.39
▸ PDE10A Q9Y233 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ LCK P06239 1/20 0.36
▸ HPGD P15428 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ PDE1A P54750 2/20 0.35
▸ PDE1B Q01064 2/20 0.35
▸ PDE1C Q14123 2/20 0.35
▸ HTR4 Q13639 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ADORA1 P30542 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30397072 0.81 PTPN1 (0.40) PTPN1CNR2PTPN2SSTR4PDE10A
SCHEMBL21893420 0.79 CNR2 (0.49) CNR2ALDH1A1GAAKDM4EHTR4
SCHEMBL25539525 0.79 CNR2 (0.50) PTPN1CNR2SSTR4ALDH1A1GAA
SCHEMBL21894543 0.79 CNR2 (0.53) PTPN1CNR2PTPN2SSTR4ALDH1A1
SCHEMBL4491096 0.74 CNR2 (0.64) CNR2POLBHPGDHTR4
SCHEMBL8234959 0.74 PTPN1 (0.60) PTPN1PTPN2SSTR4PDE10AALDH1A1
SCHEMBL19586123 0.73 DDB1 (0.59) —
SCHEMBL16548659 0.71 MEN1 (0.55) PTPN1PTPN2PDE10AALDH1A1KDM4E
SCHEMBL20674504 0.71 PTPN1 (0.56) PTPN1PTPN2SSTR4PDE10AALDH1A1
SCHEMBL31452714 0.71 PTPN1 (0.56) PTPN1PTPN2SSTR4PDE10AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220332713-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2022-10-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220332713-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP PTPN1 4046/4885CNR2 284/4885PTPN2 3965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback